These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23398832)

  • 1. The percutaneous closure of patent foramen ovale (PFO): impact on the quality of life.
    Evola S; Kauroo BA; Trovato RL; Alioto L; D'Amico G; Fonte G; Andolina G; Novo S; Assennato P
    Int J Cardiol; 2013 Sep; 168(2):1622-3. PubMed ID: 23398832
    [No Abstract]   [Full Text] [Related]  

  • 2. Quality of life after percutaneous closure of patent foramen ovale in patients after cryptogenic stroke compared to a normative sample.
    Mirzada N; Ladenvall P; Hansson PO; Eriksson P; Taft C; Dellborg M
    Int J Cardiol; 2018 Apr; 257():46-49. PubMed ID: 29422265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Residual shunt after patent foramen ovale closure: preliminary results from Italian patent foramen ovale survey.
    Caputi L; Butera G; Anzola GP; Carminati M; Carriero MR; Chessa M; Onorato E; Rigatelli G; Sangiorgi G; Santoro G; Spadoni I; Ussia GP; Vigna C; Zanchetta M; Parati E;
    J Stroke Cerebrovasc Dis; 2013 Oct; 22(7):e219-26. PubMed ID: 23352683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of echocardiography in diagnosis, monitoring closure and post-procedural assessment of patent foramen ovale.
    Davison P; Clift PF; Steeds RP
    Eur J Echocardiogr; 2010 Dec; 11(10):i27-34. PubMed ID: 21078836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of atrial fibrillation after percutaneous closure of patent foramen ovale and small atrial septal defects in patients presenting with cryptogenic stroke.
    Bonvini RF; Sztajzel R; Dorsaz PA; Righini M; Bonvin C; Alibegovic J; Sigwart U; Camenzind E; Verin V; Sztajzel J
    Int J Stroke; 2010 Feb; 5(1):4-9. PubMed ID: 20088986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
    J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of recurrent stroke after percutaneous closure of patent foramen ovale despite residual right-to-left cardiac shunt assessed by transcranial Doppler.
    van de Wyngaert F; Kefer J; Hermans C; Ovaert C; Pasquet A; Beguin C; Sindic C; Sluysmans T
    Arch Cardiovasc Dis; 2008; 101(7-8):435-41. PubMed ID: 18848685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent foramen ovale closure in post-CVA/TIA patients: psychological distress, quality of life and optimism.
    Cohen M; Daniela M; Lorber A
    Int J Clin Pract; 2010 Jan; 64(2):182-7. PubMed ID: 20089008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does closure of a patent foramen ovale have a role in the treatment of migraine with aura?
    D'Amico D; Usai S; Caputi L; Bussone G
    Neurol Sci; 2008 May; 29 Suppl 1():S23-7. PubMed ID: 18545890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of recurrent cerebrovascular events in patients with cryptogenic stroke or transient ischemic attack and patent foramen ovale: the FORI (Foramen Ovale Registro Italiano) study.
    Paciaroni M; Agnelli G; Bertolini A; Pezzini A; Padovani A; Caso V; Venti M; Alberti A; Palmiero RA; Cerrato P; Silvestrelli G; Lanari A; Previdi P; Corea F; Balducci A; Ferri R; Falcinelli F; Filippucci E; Chiocchi P; Grandi FC; Ferigo L; Musolino R; Bersano A; Ghione I; Sacco S; Carolei A; Baldi A; Ageno W;
    Cerebrovasc Dis; 2011; 31(2):109-16. PubMed ID: 21088390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous closure of patent foramen ovale in young patients with cryptogenic stroke: long-term follow-up].
    Mazuelos F; Suárez de Lezo J; Pan M; Mesa D; Delgado M; Ruiz M; Ojeda S; Esteban F
    Rev Esp Cardiol; 2008 Jun; 61(6):640-3. PubMed ID: 18570787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patent foramen ovale closure with the SeptRx device initial experience with the first "In-Tunnel" device.
    Zimmermann WJ; Heinisch C; Majunke N; Staubach S; Russell S; Wunderlich N; Sievert H
    JACC Cardiovasc Interv; 2010 Sep; 3(9):963-7. PubMed ID: 20850097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.
    Dowson A; Mullen MJ; Peatfield R; Muir K; Khan AA; Wells C; Lipscombe SL; Rees T; De Giovanni JV; Morrison WL; Hildick-Smith D; Elrington G; Hillis WS; Malik IS; Rickards A
    Circulation; 2008 Mar; 117(11):1397-404. PubMed ID: 18316488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
    Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
    Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catheter closure of patent foramen ovale in patients with cryptogenic cerebrovascular accidents: initial experiences in Japan.
    Kijima Y; Akagi T; Nakagawa K; Taniguchi M; Ueoka A; Deguchi K; Toh N; Oe H; Kusano K; Sano S; Ito H
    Cardiovasc Interv Ther; 2014 Jan; 29(1):11-7. PubMed ID: 23824518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent foramen ovale and cryptogenic stroke: many unanswered questions.
    Roth C; Alli O
    Cleve Clin J Med; 2014 Jul; 81(7):417-24. PubMed ID: 24987042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of percutaneous closure versus medical therapy for cryptogenic stroke in patients with a patent foramen ovale.
    Pickett CA; Villines TC; Ferguson MA; Hulten EA
    Am J Cardiol; 2014 Nov; 114(10):1584-9. PubMed ID: 25248812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low cerebrovascular event rate in subjects with patent foramen ovale and different clinical presentations: results from a prospective non randomized study on a population including patients with and without patent foramen ovale closure.
    Faggiano P; Frattini S; Piovesana P; Lorusso R; Chiari E; Scolari F; Padovani A; Cas LD
    Int J Cardiol; 2012 Apr; 156(1):47-52. PubMed ID: 21112103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indications, techniques and results of percutaneous patent foramen ovale closure.
    Spies C; Hijazi ZM
    Minerva Cardioangiol; 2012 Feb; 60(1):111-23. PubMed ID: 22322579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.